Cancer Research Cancer Epigenetics  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Narita, K.
Right arrow Articles by Shridhar, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Narita, K.
Right arrow Articles by Shridhar, V.
[Cancer Research 66, 6025-6032, June 15, 2006]
© 2006 American Association for Cancer Research


Molecular Biology, Pathobiology, and Genetics

HSulf-1 Inhibits Angiogenesis and Tumorigenesis In vivo

Keishi Narita1, Julie Staub1, Jeremy Chien1, Kristy Meyer2, Maret Bauer2, Andreas Friedl2, Sundaram Ramakrishnan3 and Viji Shridhar1

1 Department of Experimental Pathology, Mayo Clinic Cancer Center, Rochester, Minnesota; 2 Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin; and 3 Department of Pharmacology, University of Minnesota, Minneapolis, Minnesota

Requests for reprints: Viji Shridhar, Mayo College of Medicine, 200 First Street Southwest, Rochester, MN 55905. Phone: 507-266-2775; Fax: 507-266-5193; E-mail: shridhar.vijayalakshmi{at}mayo.edu and Andreas Friedl. E-mail: afriedl{at}facstaff.wisc.edu.

We previously identified HSulf-1 as a down-regulated gene in several tumor types including ovarian, breast, and hepatocellular carcinomas. Loss of HSulf-1, which selectively removes 6-O-sulfate from heparan sulfate, up-regulates heparin-binding growth factor signaling and confers resistance to chemotherapy-induced apoptosis. Here we report that HSulf-1 expression in MDA-MB-468 breast carcinoma clonal lines leads to reduced proliferation in vitro and reduced tumor burden in athymic nude mice in vivo. Additionally, xenografts derived from HSulf-1–expressing stable clones of carcinoma cells showed reduced vessel density, marked necrosis, and apoptosis, indicative of inhibition of angiogenesis. Consistent with this observation, HSulf-1–expressing clonal lines showed reduced staining with the endothelial marker CD31 in Matrigel plug assay, indicating that HSulf-1 expression inhibits angiogenesis. More importantly, HSulf-1 expression in the xenografts was associated with a reduced ability of vascular endothelial cell heparan sulfate to participate in a complex with fibroblast growth factor 2 (FGF-2) and its receptor tyrosine kinase FGF receptor 1c. In vitro, short hairpin RNA–mediated down-regulation of HSulf-1 in human umbilical vein endothelial cells (HUVEC) resulted in an increased proliferation mediated by heparan sulfate–dependent FGF-2, hepatocyte growth factor, and vascular endothelial growth factor 165 (VEGF165) but not by heparan sulfate–independent VEGF121. HSulf-1 down-regulation also enhanced downstream signaling through the extracellular signal–regulated kinase pathway compared with untreated cells. Consistent with the role of heparan sulfate glycosaminoglycan sulfation in VEGF-mediated signaling, treatment of HUVEC cells with chlorate, which inhibits heparan sulfate glycosaminoglycan sulfation and therefore mimics HSulf-1 overexpression, led to an attenuated VEGF-mediated signaling. Collectively, these observations provide the first evidence of a novel mechanism by which HSulf-1 modulates the function of heparan sulfate binding VEGF165 in proliferation and angiogenesis. (Cancer Res 2006; 66(12): 6025-32)




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M.-A. Frese, F. Milz, M. Dick, W. C. Lamanna, and T. Dierks
Characterization of the Human Sulfatase Sulf1 and Its High Affinity Heparin/Heparan Sulfate Interaction Domain
J. Biol. Chem., October 9, 2009; 284(41): 28033 - 28044.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. Liu, A. Khurana, R. Rattan, X. He, S. Kalloger, S. Dowdy, B. Gilks, and V. Shridhar
Regulation of HSulf-1 Expression by Variant Hepatic Nuclear Factor 1 in Ovarian Cancer
Cancer Res., June 1, 2009; 69(11): 4843 - 4850.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. C. Lamanna, M.-A. Frese, M. Balleininger, and T. Dierks
Sulf Loss Influences N-, 2-O-, and 6-O-Sulfation of Multiple Heparan Sulfate Proteoglycans and Modulates Fibroblast Growth Factor Signaling
J. Biol. Chem., October 10, 2008; 283(41): 27724 - 27735.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. K. Ambasta, X. Ai, and C. P. Emerson Jr.
Quail Sulf1 Function Requires Asparagine-linked Glycosylation
J. Biol. Chem., November 23, 2007; 282(47): 34492 - 34499.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Roy, D. Patel, S. Khanna, G. M. Gordillo, S. Biswas, A. Friedman, and C. K. Sen
Transcriptome-wide analysis of blood vessels laser captured from human skin and chronic wound-edge tissue
PNAS, September 4, 2007; 104(36): 14472 - 14477.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Narita, J. Chien, S. A. Mullany, J. Staub, X. Qian, W. L. Lingle, and V. Shridhar
Loss of HSulf-1 Expression Enhances Autocrine Signaling Mediated by Amphiregulin in Breast Cancer
J. Biol. Chem., May 11, 2007; 282(19): 14413 - 14420.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.